JP2017507165A - マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤 - Google Patents

マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤 Download PDF

Info

Publication number
JP2017507165A
JP2017507165A JP2016558550A JP2016558550A JP2017507165A JP 2017507165 A JP2017507165 A JP 2017507165A JP 2016558550 A JP2016558550 A JP 2016558550A JP 2016558550 A JP2016558550 A JP 2016558550A JP 2017507165 A JP2017507165 A JP 2017507165A
Authority
JP
Japan
Prior art keywords
formulation
antigen
polymer
release
bsa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2016558550A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017507165A5 (enExample
Inventor
アナ ジャクレネック，
アナ ジャクレネック，
ウィリアム ゲイツ，
ウィリアム ゲイツ，
フィリップ エー． エックホフ，
フィリップ エー． エックホフ，
ボリス ニコリック，
ボリス ニコリック，
ローウェル エル． ジュニア ウッド，
ローウェル エル． ジュニア ウッド，
ロバード エス． ランガー，
ロバード エス． ランガー，
タン ドゥク グエン，
タン ドゥク グエン，
ステファニー イー ツェン，
ステファニー イー ツェン，
ジェイムズ ジェイ． ノーマン，
ジェイムズ ジェイ． ノーマン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of JP2017507165A publication Critical patent/JP2017507165A/ja
Publication of JP2017507165A5 publication Critical patent/JP2017507165A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Shaping Of Tube Ends By Bending Or Straightening (AREA)
  • Micromachines (AREA)
JP2016558550A 2013-12-16 2014-12-16 マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤 Withdrawn JP2017507165A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361916555P 2013-12-16 2013-12-16
US61/916,555 2013-12-16
PCT/US2014/070664 WO2015095230A1 (en) 2013-12-16 2014-12-16 Micromolded or 3-d printed pulsatile release vaccine formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019208044A Division JP2020055818A (ja) 2013-12-16 2019-11-18 マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤

Publications (2)

Publication Number Publication Date
JP2017507165A true JP2017507165A (ja) 2017-03-16
JP2017507165A5 JP2017507165A5 (enExample) 2018-02-01

Family

ID=52396804

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016558550A Withdrawn JP2017507165A (ja) 2013-12-16 2014-12-16 マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤
JP2019208044A Pending JP2020055818A (ja) 2013-12-16 2019-11-18 マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤
JP2021085890A Active JP7682019B2 (ja) 2013-12-16 2021-05-21 マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤
JP2023042995A Pending JP2023075311A (ja) 2013-12-16 2023-03-17 マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019208044A Pending JP2020055818A (ja) 2013-12-16 2019-11-18 マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤
JP2021085890A Active JP7682019B2 (ja) 2013-12-16 2021-05-21 マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤
JP2023042995A Pending JP2023075311A (ja) 2013-12-16 2023-03-17 マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤

Country Status (6)

Country Link
US (5) US10300136B2 (enExample)
EP (2) EP3763383A1 (enExample)
JP (4) JP2017507165A (enExample)
AU (1) AU2014364930B2 (enExample)
CA (1) CA2933867A1 (enExample)
WO (1) WO2015095230A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020004652A1 (ja) * 2018-06-29 2020-01-02 学校法人同志社 エムリカサンを含む製剤
WO2020027035A1 (ja) * 2018-07-30 2020-02-06 三菱ケミカル株式会社 熱溶融型積層造形用材料
JP2023522244A (ja) * 2020-04-20 2023-05-29 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト 乾燥製剤を生成する方法
JP2023526250A (ja) * 2020-05-13 2023-06-21 マサチューセッツ インスティテュート オブ テクノロジー ポリマーマイクロデバイスの組成物およびがん免疫療法におけるその使用

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017507165A (ja) 2013-12-16 2017-03-16 マサチューセッツ インスティテュート オブ テクノロジー マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤
EP3302442B1 (en) 2015-06-03 2024-10-16 Triastek, Inc. Dosage forms and use thereof
US11395802B2 (en) * 2016-09-16 2022-07-26 Auburn University Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof
US10150282B2 (en) 2016-10-14 2018-12-11 Xerox Corporation System and method for additive manufacture of chemical delivery devices using halftone screening
AU2018212273B2 (en) 2017-01-26 2023-12-21 Triastek, Inc. Dosage forms of controlled release at specific gastrointestinal sites
WO2018165613A1 (en) 2017-03-10 2018-09-13 Prellis Biologics, Inc. Methods and systems for printing biological material
US11085018B2 (en) 2017-03-10 2021-08-10 Prellis Biologics, Inc. Three-dimensional printed organs, devices, and matrices
EP3595515A4 (en) 2017-03-14 2020-12-30 University of Connecticut BIODEGRADABLE PRESSURE SENSOR
JP2020524483A (ja) 2017-05-25 2020-08-20 プレリス バイオロジクス，インク． 三次元印刷された器官、デバイス、およびマトリックス
KR102626745B1 (ko) 2017-05-26 2024-01-17 인피니트 머티리얼 솔루션즈, 엘엘씨 수용성 중합체 조성물
US20190076631A1 (en) * 2017-09-13 2019-03-14 Massachusetts Institute Of Technology Microdevices with complex geometries
CN111698983B (zh) 2018-01-09 2022-10-18 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
CN112074227B (zh) 2018-03-05 2024-05-14 康涅狄格大学 用于经皮和脉冲药物/疫苗递送的核壳微针平台及其制造方法
WO2020028436A1 (en) 2018-07-31 2020-02-06 Prellis Biologics, Inc. Optically-induced auto-encapsulation
JP7257500B2 (ja) * 2018-08-20 2023-04-13 中国科学院過程工程研究所 マイクロカプセルに基づくワクチン
US11678989B2 (en) 2019-03-01 2023-06-20 University Of Connecticut Biodegradable piezoelectric nanofiber scaffold for bone or tissue regeneration
US11826495B2 (en) 2019-03-01 2023-11-28 University Of Connecticut Biodegradable piezoelectric ultrasonic transducer system
CN110420324B (zh) * 2019-08-01 2022-07-12 临沂大学 含兔葡萄球菌抗原的免疫原性组合物及其制备方法和应用
WO2021183626A1 (en) 2020-03-10 2021-09-16 University Of Connecticut Therapeutic bandage
US12371581B2 (en) 2020-03-25 2025-07-29 Infinite Material Solutions, Llc High performance water soluble polymer compositions
US12491290B2 (en) 2020-06-08 2025-12-09 University Of Connecticut Biodegradable piezoelectric composite materials
CN112370531B (zh) * 2020-11-18 2022-09-23 金宇保灵生物药品有限公司 一种犬瘟热、犬细小、犬腺病毒、犬副流感四联活疫苗耐热保护剂及其制备方法和应用
WO2022192361A2 (en) * 2021-03-09 2022-09-15 Board Of Regents Of The University Of Nebraska Microparticle compositions and methods use thereof
WO2022272247A1 (en) * 2021-06-21 2022-12-29 William Marsh Rice University High-throughput preparation of microparticles with pulsatile release
CN113521263A (zh) * 2021-08-03 2021-10-22 苏州大学 一种3d打印的肿瘤疫苗组合物及其制备方法与应用
WO2024026039A2 (en) * 2022-07-27 2024-02-01 Board Of Regents, The University Of Texas System Multi-channeled and guided inner controlling (magic) printheads
WO2024215759A2 (en) * 2023-04-11 2024-10-17 The Regents Of The University Of California Biodegradable scaffolds for enhancing vaccine efficacy

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504027A (ja) * 1993-10-22 1997-04-22 ジェネンテク，インコーポレイテッド ワクチンとしての使用のための抗原のマイクロカプセル化のための方法および組成物
JP2010180228A (ja) * 2001-02-13 2010-08-19 Government Of The United States Of America As Represented By The Secretary Of The Army 経皮免疫感作のためのワクチン
JP2011514337A (ja) * 2008-02-25 2011-05-06 ノババックス，インコーポレイテッド 糖ガラス化ウィルス様粒子（ｖｌｐ）
JP2011155988A (ja) * 2003-12-24 2011-08-18 Anza Therapeutics Inc 抗原および細菌分泌シグナルポリペプチドを含む融合タンパク質をコードする組換え核酸分子、発現カセット、および細菌、ならびにこれらを使用する方法

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450150A (en) 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US5490962A (en) 1993-10-18 1996-02-13 Massachusetts Institute Of Technology Preparation of medical devices by solid free-form fabrication methods
US7070590B1 (en) 1996-07-02 2006-07-04 Massachusetts Institute Of Technology Microchip drug delivery devices
WO1999009956A1 (en) 1997-08-29 1999-03-04 Corixa Corporation Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof
EP1242131A4 (en) 1999-10-12 2006-05-03 Univ Ohio State REACTIVE POLYMER VALVE, DISPENSING UNITS AND METHODS THAT USE THIS VALVE
ATE323470T1 (de) 1999-12-10 2006-05-15 Massachusetts Inst Technology Mikrochip-arzneistoffverabreichungssysteme und herstellungsverfahren
US20040175410A1 (en) 2000-04-26 2004-09-09 Control Delivery Systems, Inc. Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
US6565532B1 (en) 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US20040033241A1 (en) * 2000-06-02 2004-02-19 Allergan, Inc. Controlled release botulinum toxin system
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
MXPA04002973A (es) * 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosis de liberacion modificada.
US7285289B2 (en) 2002-04-12 2007-10-23 Nagy Jon O Nanoparticle vaccines
ES2316791T3 (es) * 2002-05-06 2009-04-16 Massachusetts Institute Of Technology Forma de dosificacion controlada por difusion y metodo de fabricacion inclusive impresion tridimensional.
US8545830B2 (en) 2003-03-24 2013-10-01 University Of Tennessee Research Foundation Multi-functional polymeric materials and their uses
WO2005010240A2 (en) 2003-07-17 2005-02-03 Microchips, Inc. Low temperature methods for hermetically sealing reservoir devices
WO2005046620A2 (en) 2003-11-12 2005-05-26 The General Hospital Corporation Variable appearance tissue markings
US9040090B2 (en) 2003-12-19 2015-05-26 The University Of North Carolina At Chapel Hill Isolated and fixed micro and nano structures and methods thereof
CA2551644C (en) 2003-12-24 2014-03-04 Cerus Corporation Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of usethereof
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
WO2006121819A1 (en) 2005-05-06 2006-11-16 Board Of Regents, The University Of Texas System Methods for fabricating nano and microparticles for drug delivery
KR20080024206A (ko) 2005-06-20 2008-03-17 엘란 파마 인터내셔널 리미티드 아릴-헤테로시클릭 화합물을 함유하는 나노입자형 조절방출 조성물
WO2007012114A1 (en) 2005-07-25 2007-02-01 Nanotechnology Victoria Pty Ltd Microarray device
WO2007016337A2 (en) 2005-07-28 2007-02-08 Mformation Technologies, Inc. System and method for service quality management for wireless devices
US20070141106A1 (en) 2005-10-19 2007-06-21 Bonutti Peter M Drug eluting implant
US20080026040A1 (en) * 2006-07-31 2008-01-31 Isaac Farr Active agent-releasing dosage forms
US8349326B2 (en) 2007-02-20 2013-01-08 Tufts University Methods and systems for multi-antibody therapies
WO2009042231A2 (en) 2007-09-27 2009-04-02 Akina, Inc. Sol-gel phase-reversible hydrogel templates and uses thereof
MX2010003642A (es) 2007-10-12 2010-08-09 Massachusetts Inst Technology Nanotecnologia de vacuna.
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
US10463608B2 (en) 2008-09-29 2019-11-05 The Corporation Of Mercer University Microneedle-based transdermal delivery system and method of making same
EP2427179A4 (en) 2009-05-04 2013-09-11 Psivida Inc POROUS PARTICLES FOR THE RELEASE OF SILICIUM MEDICINES
AU2010276511B2 (en) 2009-07-31 2013-09-19 Kindeva Drug Delivery L.P. Hollow microneedle arrays
US10046109B2 (en) 2009-08-12 2018-08-14 Progenity, Inc. Drug delivery device with compressible drug reservoir
WO2011156641A2 (en) 2010-06-09 2011-12-15 Kaspar Roger L Microneedle arrays for active agent delivery
MX373096B (es) * 2010-12-02 2020-04-27 Oncolytics Biotech Inc Formulaciones virales líquidas.
WO2012088306A2 (en) 2010-12-22 2012-06-28 Psivida Us, Inc. Two-piece injectable drug delivery device with heat-cured seal
JP2012235899A (ja) 2011-05-12 2012-12-06 Bioserentack Co Ltd 大量の目的物質を皮膚内へデリバリーするためのマイクロニードル・アレイ・チップ
US20130046182A1 (en) 2011-08-16 2013-02-21 Elwha LLC, a limited liability company of the State of Delaware Devices and Methods for Recording Information on a Subject's Body
KR101542549B1 (ko) 2011-09-02 2015-08-06 산디아 코포레이션 바이오센싱 및 약물 전달을 위한 마이크로니들 어레이
CN103251941A (zh) 2012-02-16 2013-08-21 海南大学 动物病毒性疫苗脉冲释放系统、其制备方法及用途
IN2014DN10765A (enExample) 2012-05-30 2015-09-04 Univ California
TWI554289B (zh) 2012-06-29 2016-10-21 國立成功大學 鑲嵌式經皮藥物釋放貼片及其製造方法
JP2015522342A (ja) 2012-06-29 2015-08-06 イーエルシー マネージメント エルエルシー １つ以上の化粧品成分を含むマイクロニードル
RU2695536C2 (ru) 2013-03-12 2019-07-23 Айпоинт Фармасьютикалз Юэс, Инк. Устройство для доставки лекарственных средств, содержащее частицы носителя на основе кремния
ITTO20130284A1 (it) 2013-04-09 2014-10-10 Fond Istituto Italiano Di Tecnologia Procedimento per la produzione di microparticelle polimeriche sagomate
US10232157B2 (en) 2013-07-16 2019-03-19 3M Innovative Properties Company Hollow microneedle with beveled tip
JP2017507165A (ja) 2013-12-16 2017-03-16 マサチューセッツ インスティテュート オブ テクノロジー マイクロモールド成形された、または３次元印刷されたパルス放出ワクチン製剤
AU2015264090A1 (en) 2014-05-21 2016-12-15 Invention Development Management Company, Llc Tattoo and tattoo applicator for animal lifecycle monitoring
AU2015343369B2 (en) 2014-11-03 2018-11-22 Georgia Tech Research Corporation Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
WO2016176327A1 (en) 2015-04-27 2016-11-03 University Of Rochester Nanoparticle therapeutics for treating skin inflammatory disorders
US20190336532A1 (en) 2016-12-21 2019-11-07 Fred Hutchinson Cancer Research Center Scaffolds to treat solid tumor cells and escape variants
CN111093629A (zh) 2017-07-16 2020-05-01 麻省理工学院 微针纹身贴剂和其用途
US20190076631A1 (en) 2017-09-13 2019-03-14 Massachusetts Institute Of Technology Microdevices with complex geometries
GB201919428D0 (en) 2019-12-30 2020-02-12 Immodulon Therapeutics Ltd Immunotherapeutic treatment of cancer
IL298019A (en) 2020-05-13 2023-01-01 Massachusetts Inst Technology Compositions of polymeric microdevices and their use in cancer immunotherapy
CN113350564B (zh) 2021-05-20 2023-03-10 诺一迈尔(苏州)生命科技有限公司 生物可降解组织粘合贴片及其制备方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504027A (ja) * 1993-10-22 1997-04-22 ジェネンテク，インコーポレイテッド ワクチンとしての使用のための抗原のマイクロカプセル化のための方法および組成物
JP2010180228A (ja) * 2001-02-13 2010-08-19 Government Of The United States Of America As Represented By The Secretary Of The Army 経皮免疫感作のためのワクチン
JP2011155988A (ja) * 2003-12-24 2011-08-18 Anza Therapeutics Inc 抗原および細菌分泌シグナルポリペプチドを含む融合タンパク質をコードする組換え核酸分子、発現カセット、および細菌、ならびにこれらを使用する方法
JP2011514337A (ja) * 2008-02-25 2011-05-06 ノババックス，インコーポレイテッド 糖ガラス化ウィルス様粒子（ｖｌｐ）

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ADVANCED DRUG DELIVERY REVIEWS, vol. 65, JPN6019027399, 13 July 2013 (2013-07-13), pages 1611 - 1625, ISSN: 0004077229 *
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, vol. 53, no. 2, JPN6018039086, March 2013 (2013-03-01), pages 136 - 144, ISSN: 0004213446 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020004652A1 (ja) * 2018-06-29 2020-01-02 学校法人同志社 エムリカサンを含む製剤
JPWO2020004652A1 (ja) * 2018-06-29 2021-07-15 学校法人同志社 エムリカサンを含む製剤
JP7340863B2 (ja) 2018-06-29 2023-09-08 学校法人同志社 エムリカサンを含む製剤
WO2020027035A1 (ja) * 2018-07-30 2020-02-06 三菱ケミカル株式会社 熱溶融型積層造形用材料
JPWO2020027035A1 (ja) * 2018-07-30 2021-08-02 三菱ケミカル株式会社 熱溶融型積層造形用材料
JP7355016B2 (ja) 2018-07-30 2023-10-03 三菱ケミカル株式会社 熱溶融型積層造形用材料
US12043730B2 (en) 2018-07-30 2024-07-23 Mitsubishi Chemical Corporation Fused deposition modeling type additive manufacturing material
JP2023522244A (ja) * 2020-04-20 2023-05-29 エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト 乾燥製剤を生成する方法
JP2023526250A (ja) * 2020-05-13 2023-06-21 マサチューセッツ インスティテュート オブ テクノロジー ポリマーマイクロデバイスの組成物およびがん免疫療法におけるその使用
JP7776145B2 (ja) 2020-05-13 2025-11-26 マサチューセッツ インスティテュート オブ テクノロジー ポリマーマイクロデバイスの組成物およびがん免疫療法におけるその使用

Also Published As

Publication number Publication date
US20210205444A1 (en) 2021-07-08
AU2014364930B2 (en) 2017-06-15
JP2021120413A (ja) 2021-08-19
WO2015095230A1 (en) 2015-06-25
US10300136B2 (en) 2019-05-28
US10960073B2 (en) 2021-03-30
US20260224697A1 (en) 2026-08-06
US12622963B2 (en) 2026-05-12
US20190328871A1 (en) 2019-10-31
US20150165020A1 (en) 2015-06-18
AU2014364930A1 (en) 2016-07-14
JP7682019B2 (ja) 2025-05-23
CA2933867A1 (en) 2015-06-25
EP3763383A1 (en) 2021-01-13
US20240181047A1 (en) 2024-06-06
US11975069B2 (en) 2024-05-07
EP3082852B1 (en) 2020-06-17
JP2020055818A (ja) 2020-04-09
JP2023075311A (ja) 2023-05-30
EP3082852A1 (en) 2016-10-26

Similar Documents

Publication Publication Date Title
US12622963B2 (en) Micromolded or 3-D printed pulsatile release vaccine formulations
Bale et al. Overview on therapeutic applications of microparticulate drug delivery systems
Miladi et al. Particles from preformed polymers as carriers for drug delivery
US9878036B2 (en) Immunomodulatory compositions comprising a polymer matrix and an oil phase
CA3082793C (en) Microdevices with complex geometries
Walters et al. Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy
Cheng et al. Nanotechnology-based strategies for vaccine development: accelerating innovation and delivery
Johansen et al. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs
Li et al. Advanced materials for the delivery of vaccines for infectious diseases
Diesner et al. Use of lectin-functionalized particles for oral immunotherapy
Tressa et al. Novel Nanocarriers Microencapsulation: Current, Patents and Clinical Trials Comprehensive Review.
de Souza et al. A systematic review of functionalized polymeric nanoparticles to improve intestinal permeability of drugs and biological products
D'Souza Nanoparticulate vaccine delivery systems
Pal et al. Drug Delivery to the Immune System: Immunotherapies and Vaccines
Kumar et al. Poly-Lactide/Poly-Lactide-co-Glycolide-Based Delivery System for Bioactive Compounds against Microbes
van der Kooij et al. Microfluidic production of polymeric Core-Shell microspheres for the delayed pulsatile release of bovine serum albumin as a model antigen. Pharmaceutics 2021; 13: 1854
Schiller Scalable processes to manufacture nanoparticulate dosage forms for oral vaccination
Lin et al. The preparation and characteristic of poly (lactide co–glycolide) microspheres as novel antigen delivery systems
as Promising Biolological Medicinal Chemistry
Iqbal Preparation of submicron particles for theranostic applications: imaging and therapy
Jang Development of a lower intestine targeting mucoadhesive platform of oral drug delivery
Hussein et al. Polymeric micro and nanoparticles as promising drug delivery vehicles: a review

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171215

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180309

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180309

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181004

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190227

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190717

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20191217

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20200114

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20200214

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20200220